Forskning ved Københavns Universitet - Københavns Universitet


A Gene Expression Signature Associated With Overall Survival in Patients With Hepatocellular Carcinoma Suggests a New Treatment Strategy

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Jean-Pierre Gillet
  • Andersen, Jesper Bøje
  • James P Madigan
  • Sudhir Varma
  • Rachel K Bagni
  • Katie Powell
  • William E Burgan
  • Chung-Pu Wu
  • Anna Maria Calcagno
  • Suresh V Ambudkar
  • Snorri S Thorgeirsson
  • Michael Gottesman

Despite improvements in the management of liver cancer, the survival rate for individuals with hepatocellular carcinoma (HCC) remains dismal. The survival benefit of systemic chemotherapy for the treatment of liver cancer is only marginal. Although the reasons for treatment failure are multifactorial, intrinsic resistance to chemotherapy plays a primary role. Here, we analyzed the expression of 377 multidrug resistance-associated genes in two independent cohorts of patients with advanced hepatocellular carcinoma, with the aim of finding ways to improve survival in this poor-prognosis cancer. Taqman-based qPCR revealed a 45-gene signature that predicts overall survival (OS) in patients with HCC. Using the Connectivity Map Tool, we were able to identify drugs that converted the gene expression profiles of HCC cell lines from ones matching patients with poor OS to profiles associated with good OS. We found three compounds that convert the gene expression profiles of three HCC cell lines to gene expression profiles associated with good OS. These compounds increase histone acetylation, which correlates with the synergistic sensitization of those multidrug-resistant tumor cells to conventional chemotherapeutic agents including cisplatin, sorafenib and 5-fluorouracil. Our results indicate that it is possible to modulate gene expression profiles in HCC cell lines to those associated with better outcome. This approach also increases sensitization of HCC cells towards conventional chemotherapeutic agents. This work suggests new treatment strategies for a disease for which few therapeutic options exist.

TidsskriftMolecular Pharmacology
Udgave nummer2
Sider (fra-til)263-272
Antal sider9
StatusUdgivet - 2016
Eksternt udgivetJa

ID: 151949212